Pancreatic Cancer Research

ResearcherPurdue University West LafayetteNo recent work listed

Stephen F Konieczny

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-3281-3714; OpenAlex author ID A5014807279; NIH RePORTER profile ID 1919792. Sources: OpenAlex.

Their work

Papers
11 (first author 0, last author 2)
Trials
0
Grants
3
Labs led
1
Collaborators
29
Papers, trials and grants by year

2013: 1 paper · 2014: none · 2015: 1 paper · 2016: 2 papers · 2017: 2 grants · 2018: 1 paper · 2019: 2 papers · 2020: 2 papers · 2021: 1 paper · 2022: 1 paper, 1 grant

Papers 11

  1. Targeting Plk1 Sensitizes Pancreatic Cancer to Immune Checkpoint Therapy. Co-author DOI 10.1158/0008-5472.can-22-0018↗
  2. Thrombin-PAR1 signaling in pancreatic cancer promotes an immunosuppressive microenvironment. Last author DOI 10.1111/jth.15115↗
  3. A Biomimetic Tumor Model of Heterogeneous Invasion in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1002/smll.201905500↗
  4. An engineered pancreatic cancer model with intra-tumoral heterogeneity of driver mutations. Co-author DOI 10.1039/d0lc00707b↗
  5. Identification and Characterization of AES-135, a Hydroxamic Acid-Based HDAC Inhibitor That Prolongs Survival in an Orthotopic Mouse Model of Pancreatic Cancer. Co-author DOI 10.1021/acs.jmedchem.8b01957↗
  6. Thrombin Signaling Promotes Pancreatic Adenocarcinoma through PAR-1-Dependent Immune Evasion. Co-author DOI 10.1158/0008-5472.can-18-3206↗
  7. Induced PTF1a expression in pancreatic ductal adenocarcinoma cells activates acinar gene networks, reduces tumorigenic properties, and sensitizes cells to gemc… Last author DOI 10.1002/1878-0261.12314↗
  8. Abrogating cholesterol esterification suppresses growth and metastasis of pancreatic cancer. Co-author DOI 10.1038/onc.2016.168↗
  9. Plk1 inhibition enhances the efficacy of gemcitabine in human pancreatic cancer. Co-author DOI 10.1080/15384101.2016.1148838↗
  10. The basic helix-loop-helix transcription factor E47 reprograms human pancreatic cancer cells to a quiescent acinar state with reduced tumorigenic potential. Co-author DOI 10.1097/mpa.0000000000000328↗
  11. Plk1 phosphorylation of orc2 and hbo1 contributes to gemcitabine resistance in pancreatic cancer. Co-author DOI 10.1158/1535-7163.mct-12-0632↗

Grants 3

  1. Thrombin-dependent mechanisms of pancreatic ductal adenocarcinoma disease R01CA211098↗
  2. Kras-Induced Cellular Plasticity in Pancreatic Cancer R01CA124586↗
  3. Pancreas Transcription Factors and Disease Model Systems R01DK055489↗

Closest collaborators

The 25 strongest of 29 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Matthew J. Flick · 2 shared papers, 1 shared grant, 2019–2022 · strength 0.87
  2. Yi Yang · 6 shared papers, 2016–2021 · strength 0.63
  3. Patrick G. Schweickert · 4 shared papers, 2016–2021 · strength 0.35
  4. Bumsoo Han · 2 shared papers, 2020 · strength 0.28
  5. Xiaoqi Liu · 4 shared papers, 2013–2022 · strength 0.27
  6. Michael J. Bradney · 1 shared paper, 2020 · strength 0.15
  7. Hye‐ran Moon · 1 shared paper, 2020 · strength 0.13
  8. Brad L. Jakubison · 2 shared papers, 2015–2018 · strength 0.13
  9. Pamela Itkin‐Ansari · 2 shared papers, 2015–2018 · strength 0.13
  10. Nigel Mackman · 1 shared paper, 2021 · strength 0.12
  11. Emily White · 1 shared paper, 2021 · strength 0.12
  12. Lijun Cheng · 1 shared paper, 2022 · strength 0.12
  13. Zhuangzhuang Zhang · 1 shared paper, 2022 · strength 0.12
  14. Yunlong Liu · 1 shared paper, 2018 · strength 0.08
  15. Melissa L. Fishel · 1 shared paper, 2019 · strength 0.07
  16. Andrew E. Shouksmith · 1 shared paper, 2019 · strength 0.07
  17. Fenil Shah · 1 shared paper, 2019 · strength 0.07
  18. Patrick Thomas Gunning · 1 shared paper, 2019 · strength 0.07
  19. Jie Li · 1 shared paper, 2016 · strength 0.06
  20. Nihal Ahmad · 1 shared paper, 2016 · strength 0.06
  21. J-X Cheng · 1 shared paper, 2016 · strength 0.05
  22. Shaoxiong Chen · 1 shared paper, 2016 · strength 0.05
  23. Dongsheng Gu · 1 shared paper, 2016 · strength 0.05
  24. Junjie Li · 1 shared paper, 2016 · strength 0.05
  25. Jingwu Xie · 1 shared paper, 2016 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.